Opt-in versus universal codeine provision for medical abortion up to 10 weeks of gestation at British Pregnancy Advisory Service: a cross-sectional evaluation.

Neda Taghinejadi Hannah McCulloch Michal Krassowski Amelia McInnes-Dean Katherine C Whitehouse Patricia A Lohr

Published in: BMJ sexual & reproductive health (2024)

Our findings suggest that patients have a better experience with pain management during medical abortion when able to opt-in to codeine provision following counselling versus receiving this medication routinely.

Keyphrases

pain management
healthcare
end stage renal disease
ejection fraction
newly diagnosed
chronic pain
mental health
peritoneal dialysis
preterm infants
preterm birth
pregnant women
hepatitis c virus
human immunodeficiency virus
drug induced
clinical evaluation